Cancer Immunotherapy Trials Network
Martin "Mac" Cheever, MD Principal Investigator of the CITN
Dr. Cheever is the Principal Investigator at CITN responsible for the Central Operations & Statistical Center (COSC). He is also the Director of the Solid Tumor Research for the Fred Hutchinson Cancer Research Center (FHCRC).
Mary L. “Nora” Disis, MD, Co-Investigator of the CITN
Dr. Disis is the Co-Investigator responsible for immune monitoring. Dr. Disis is the Associate Dean for Translational Health Sciences in the UW School of Medicine, Professor of Medicine and Adjunct Professor of Pathology and Obstetrics and Gynecology at UW.
Kim Margolin, MD, Co-Investigator of the CITN
Dr. Margolin has shared responsibility for organization & trial development at CITN. Dr. Margolin joined Seattle Cancer Care Alliance as a Professor at the University of Washington and a member of the Fred Hutchinson Cancer Research Center.
John Thompson, MD , CITN Consultant – Phase I/II protocol design
Dr. Thompson is a University of Washington professor , Medical Oncology Division,. He is the director Phase I Clinical Trials Program at Seattle Cancer Care Alliance and member of clinical trial division at the Fred Hutchinson Cancer Research Center.
Francesco Marincola, MD, FACS –CITN Consultant, Immune monitoring
Dr. Marincola is Chief of the Infectious Disease and Immunogenetics Section in the Department of Transfusion Medicine at the Clinical Center of the NIH in Bethesda. Dr Marincola will consult on the scientific and quality control of immune monitoring aspects of the CITN.
Anna Karolina Palucka, MD, PhD, CITN Consultant
Analysis of blood transcriptional profiles and biomarker signatures
Dr. Palucka is an Investigator, Baylor Institute for Immunology Research, Dallas, Texas and a Professor, Department of Gene & Cell Medicine, Mt. Sinai School of Medicine.